Lacrimal Duct Stent Tube Sales to Reach US$ 40 Mn in 2029
The global lacrimal duct stent tube market has been growing on the back of increasing healthcare expenditure in tandem with expanding patient pool for nasolacrimal duct obstruction. As the demand for treatments with minimal invasions as well as better success rates ascends at a healthy pace, the worldwide sales of lacrimal duct stent tubes will value about US$ 40 Mn by 2029 end.
FREQUENTLY ASKED QUESTIONS ABOUT LACRIMAL DUCT STENT TUBE MARKET
Which region is expected to lead in terms of revenue in lacrimal duct stent tube market?
North America remains most lucrative region in terms of revenue and is anticipated to grow at an impressive rate during the forecast period. India, China, and Brazil are expected to be targeted geographies for incremental opportunity for regional and major players.
Which product segment would be most attractive for investments?
Bicanalicular lacrimal duct stent tube emerged as the attractive segment by product type representing 3/4th of revenue share in the lacrimal duct stent tube market. Easier usability, improved patient compliance, material compatibility of bicanalicular lacrimal duct stent with patient without causing any adverse reaction are key pointers in driving growth of the segment.
Which end users would contribute maximum revenue during the forecast period?
Hospitals are expected to hold half of the total market revenue share during the forecast period. Ophthalmic clinics are anticipated to be second most attractive segment owing to increase in number of surgeries and number of cases related to nasolacrimal duct obstruction.
Who are the major players in the lacrimal duct stent tube market?
FCI Ophthalmics, Kaneka Corporation are the key players in the lacrimal duct stent tube market. New product development is the key strategy folowed by these players. Effective marketing strategy among ophthalmologists and cost effectivity are other criterias that manufacturers are competing on.
What complications associated with stent tubes are hampering market growth?
Corneal abrasion is the most common complication encountered during treatment procedure. To overcome this complication, manufacturers in the lacrimal duct stent tube market are focusing on altering the length of stent, material used for manufacturing, etc. The process still has risk of complications, considering the age group in which stenting is carried out. These complications may hamper the potential growth of the market.
Bicanalicular Lacrimal Duct Stent Tube Holds Nearly 3/4th Share
Bicanalicular lacrimal duct stent tubes continue to be top-selling owing to their easier usability, improved patient compliance, material compatibility, and better clinical outcomes. Bicanalicular lacrimal duct stent tubes represent nearly 75% share of global market value which would be a continuing trend in the market through 2029. Further, monocanalicular lacrimal duct stent tubes, though have been observing a healthy adoption rate in the recent past, will see subsequent decline in sales during the foreseeable period.
North America and East Asia at Forefront
The growth of healthcare industry has been inflating in developed regions that are embracing a value-centric business model. This is bolstering the adoption of lacrimal duct stent tubes in developed regions such as North America, which accounted for around 46% revenue share in global market. On the back of rising per capita healthcare spending and numerous government initiatives for integrated healthcare systems in the region, East Asia also remains a key contributor to the global market value. Furthermore, the swelling patient pool for retinal diseases in both the regions is again attracting stakeholders’ investments.
* This data is only a representation. Actual data may vary and will be available in report.
Gaining Competitiveness with Product Innovation and Promotional Activities
Manufacturers must focus on product innovations for lacrimal duct stent tubes. For instance, FCI Ophthalmic developed a complete line of BIKA stents - BIKA, BIKA for DCR, and Infant BIKA - covering a range of sizes that will be helpful in treating most of the congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) cases. Market players should also raise awareness among healthcare professionals about the benefits of devices for nasolacrimal duct obstruction management via promotional activities in order to reap significant returns.
Bicanalicular lacrimal duct stent tube continue to see worthwhile sales
Preference for monocanalicular lacrimal duct stent tube on decline
Hospitals continue to register substantial adoption
Demand from ophthalmic clinics to increase
How Growth will Unfold
By capturing a market share of around 50% throughout the period of projection, hospitals are slated to remain the prominent end-users of lacrimal duct stent tubes. As lacrimal duct stent tubes along with DCR procedure are minimally invasive, their adoption across hospitals has promisingly increased. Moreover, outpatient clinics such as ophthalmic clinics and ambulatory surgical centers (ASC) are showcasing rapid adoption of lacrimal duct stent tubes, which are again garnering manufacturers’ attention.
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
Lacrimal Duct Stent Tube Market Analysis 2019-2029
A recent market study published by Future Market Insights (FMI) on the lacrimal duct stent tube including global industry analysis for 2014-2018 & opportunity assessment for 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the lacrimal duct stent tube market, growth prospects are obtained with maximum precision.
Lacrimal Duct Stent Tube Market Taxonomy
The global lacrimal duct stent tube is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
- Monocanalicular Lacrimal Duct Stent Tube
- Bicanalicular Lacrimal Duct Stent Tube
- Ophthalmic Clinics
- Ambulatory Surgical Centers
- North America
- Latin America
- East Asia
- South Asia
- Middle East & Asia (MEA)
The report initiates with the executive summary of the lacrimal duct stent tube market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the lacrimal duct stent tube market.
Readers can find the definition and a detailed segmentation of the lacrimal duct stent tube market in this chapter, which will help them understand the basic information about the market.
This chapter explains the key trends that are expected to influence the growth of the lacrimal duct stent tube market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.
This section explains the global market volume analysis and forecast for the lacrimal duct stent tube during the forecast period. This chapter includes a detailed analysis of the historical lacrimal duct stent tube market.
This section includes premium insights such as pricing analysis and epidemiology of nasolacrimal duct obstruction.
This section explains the global market value analysis and forecast for the lacrimal duct stent tube during the forecast period. This chapter includes a detailed analysis of the historical lacrimal duct stent tube market.
This section includes premium insights such as macroeconomic factors, drivers, opportunity and restrains.
Based on product, the lacrimal duct stent tube market is segmented into monocanalicular lacrimal duct stent tube and bicanalicular lacrimal duct stent tube. In this chapter, readers can find information about the key trends and developments in the lacrimal duct stent tube and market attractiveness analysis based on product.
This chapter provides details about the lacrimal duct stent tube market based on end user, and has been classified into hospitals, ophthalmic clinics and ambulatory surgical centers. In this chapter, readers can understand the market attractiveness analysis based on end user.
This chapter explains how the lacrimal duct stent tube market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa (MEA).
This chapter includes a detailed analysis of growth of the North America Lacrimal Duct Stent Tube market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America.
This chapter provides the growth scenario of the lacrimal duct stent tube market in Latin American countries such as Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
This chapter provides the growth scenario of the lacrimal duct stent tube market in Europe in several countries such as Germany, the U.K., France, Spain, Italy, BENELUX, Russia and the Rest of Europe are included in this chapter.
This chapter provides the growth scenario of the lacrimal duct stent tube market in East Asia in several countries such as China, Japan and South Korea are included in this chapter.
This chapter highlights the growth of the lacrimal duct stent tube in South Asia by focusing on India, Thailand, Indonesia, Malaysia, rest of South Asia. This section also help readers understand the key factors that are responsible for the growth of the lacrimal duct stent tube market in South Asia.
This chapter highlights the growth of the lacrimal duct stent tube in Australia and New Zealand. This section also help readers understand the key factors that are responsible for the growth of the lacrimal duct stent tube market in Oceania.
This chapter provides information about how the lacrimal duct stent tube market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period (2019-2029).
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the lacrimal duct stent tube market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are FCI Ophthalmics, Kaneka Corporation (Kaneka Pharma America LLC), Gunther Weiss Scientific Glass, Bess Medizintechnik Gmbh.
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the lacrimal duct stent tube report.
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the lacrimal duct stent tube.
How the research was conducted?
- Marketing Directors
- Product Managers
- Business Development Officers
- Production Managers
- Sales Executives
- Industry Experts
- Current Market Dynamics and Challenges
- Yesteryear Trends
- Market Characteristics
- Market Performance and Growth Quadrants
- Strategic Growth Initiatives
- Near-term and Long-Term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- American Journal of Ophthalmology
- Company Press Releases
- Annual Reports and Investor Presentations
- Research Papers
- Government Websites and Publications
Primary Interview Splits